John Haughney Selected Research

Nebulizers and Vaporizers (Inhaler)

1/2022	Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD): Measurement Properties of Novel Patient-Reported Symptom Measures.
1/2022	Environmental Sustainability in Respiratory Care: An Overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) Programme.
1/2021	Peak Inspiratory Flow Measured at Different Inhaler Resistances in Patients with Asthma.
1/2020	A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD.
12/2019	A multinational observational study identifying primary care patients at risk of overestimation of asthma control.
1/2018	A review of asthma care in 50 general practices in Bedfordshire, United Kingdom.
7/2017	Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes.
1/2016	Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.
1/2016	Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting.
4/2015	Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Haughney Research Topics

Disease

33	Asthma (Bronchial Asthma) 01/2022 - 01/2002
18	Chronic Obstructive Pulmonary Disease (COPD) 04/2022 - 12/2012
4	Infections 12/2021 - 01/2010
3	COVID-19 01/2022 - 12/2021
3	Respiratory Tract Infections (Respiratory Tract Infection) 07/2013 - 10/2011
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 12/2012
2	Rhinitis 01/2020 - 12/2009
2	Inflammation (Inflammations) 01/2019 - 06/2015
2	Obesity 01/2016 - 10/2011
1	Heart Diseases (Heart Disease) 04/2022
1	Heart Failure 04/2022
1	Fatigue 01/2022
1	Pain (Aches) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Disease Progression 01/2019
1	Nausea 10/2018
1	Headache (Headaches) 10/2018
1	Pneumonia (Pneumonitis) 11/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Eosinophilia 06/2015
1	Allergic Rhinitis 10/2011
1	Gastroesophageal Reflux (GERD) 10/2011

Drug/Important Bio-Agent (IBA)

20	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 10/2004
6	Formoterol Fumarate (Oxis)FDA Link 01/2016 - 10/2004
5	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 01/2010
4	Bronchodilator Agents (Bronchodilators)IBA 04/2022 - 10/2011
4	GoldIBA 01/2019 - 04/2014
4	Beclomethasone (Beclometasone)FDA Link 01/2019 - 01/2002
4	Budesonide (Pulmicort)FDA LinkGeneric 02/2012 - 10/2004
3	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2018
3	VaccinesIBA 01/2022 - 12/2021
3	Theophylline (Theon)FDA LinkGeneric 01/2019 - 06/2015
3	SteroidsIBA 06/2015 - 12/2007
2	BNT162 VaccineIBA 01/2022 - 12/2021
2	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022 - 11/2020
2	Pharmaceutical PreparationsIBA 01/2019 - 12/2012
1	Bisoprolol (Concor)FDA LinkGeneric 04/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	CarbonIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	AutoantibodiesIBA 01/2021
1	Histamine Antagonists (Antihistamines)IBA 01/2020
1	insulin receptor-related receptor (IRR)IBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Immunoglobulin E (IgE)IBA 01/2018
1	aclidinium bromideIBA 01/2016
1	Muscarinic AntagonistsIBA 01/2016
1	PeriostinIBA 06/2015
1	Albuterol (Salbutamol)FDA LinkGeneric 12/2013
1	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 12/2013
1	Generic DrugsIBA 12/2013
1	Formoterol Fumarate Drug Combination Budesonide FDA Link 02/2012
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2011
1	apaflurane (hydrofluoroalkane)IBA 01/2002

Therapy/Procedure

21	Nebulizers and Vaporizers (Inhaler) 01/2022 - 10/2004
15	Therapeutics 12/2019 - 12/2008
6	Metered Dose Inhalers (Metered Dose Inhaler) 01/2021 - 01/2010
5	Dry Powder Inhalers 01/2021 - 01/2010
1	Biological Therapy 01/2018
1	Drug Therapy (Chemotherapy) 05/2014